Homo sapiens resistin like beta (RETNLB), transcript variant 2, mRNA

Run BLAST
Find regions of similarity between this sequence and other sequences using BLAST.
Pick Primers
Design and test primers for this sequence using Primer-BLAST.

Resistin-like beta reduction is associated to low survival rate and is downregulated by adjuvant therapy in colorectal cancer patients. [Sci Rep. 2023]
Resistin-like beta reduction is associated to low survival rate and is downregulated by adjuvant therapy in colorectal cancer patients.
Di Rosa M, Di Cataldo A, Broggi G, Caltabiano R, Tibullo D, Castrogiovanni P, Imbesi R, Lanteri R, Salomone F, Raciti G, et al. Sci Rep. 2023 Jan 27; 13(1):1490. Epub 2023 Jan 27.
Investigating resistin like beta (RETNLB) as a tumor promoter for oral squamous cell carcinoma. [Head Face Med. 2021]
Investigating resistin like beta (RETNLB) as a tumor promoter for oral squamous cell carcinoma.
Jin H, Miao H, Nie YW, Lin YY. Head Face Med. 2021 Jun 22; 17(1):20. Epub 2021 Jun 22.
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. [Cell. 2021]
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
Huttlin EL, Bruckner RJ, Navarrete-Perea J, Cannon JR, Baltier K, Gebreab F, Gygi MP, Thornock A, Zarraga G, Tam S, et al. Cell. 2021 May 27; 184(11):3022-3040.e28. Epub 2021 May 6.

RefSeq protein product
See the reference protein sequence for resistin-like beta isoform 2 (NP_001399112.1).

Homo sapiens resistin like beta (RETNLB), transcript variant 1, mRNA
Homo sapiens resistin like beta (RETNLB), transcript variant 1, mRNA
gi|1908918664|ref|NM_032579.3|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Nucleotide